ISPOR - Polona Jaki Mekjavić

Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Ischemic and Nonischemic Heart Failure With Reduced Ejection Fraction: Perspective From a Universal Healthcare System

May 1, 2025, 00:00

Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Ischemic and Nonischemic Heart Failure With Reduced Ejection Fraction: Perspective From a Universal Healthcare System

May 1, 2025, 00:00

Polona Jaki Mekjavić

Sep 18, 2019, 08:26 AM

First Name : Polona

Last Name : Jaki Mekjavić

Degrees : MD, PhD

Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Ischemic and Nonischemic Heart Failure With Reduced Ejection Fraction: Perspective From a Universal Healthcare System

May 1, 2025, 00:00

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now